List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1060 studies with search of:   "Anemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Conditions: Anemia, Aplastic;   Red-Cell Aplasia, Pure;   Anemia, Diamond-Blackfan
Intervention: Drug: Rituximab (Rituxan)
2 Recruiting Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Conditions: Congenital Hemolytic Anemia;   Diamond-Blackfan Anemia
Interventions: Procedure: Radiotherapy;   Drug: Alemtuzumab (Campath® (Registered Trademark));   Drug: Sirolimus (Rapamune® (Registered Trademark))
3 Completed Study of Deferasirox in Iron Overload From Beta-Thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
Conditions: Beta-Thalassemia;   Myelodysplastic Syndromes;   Fanconi Syndrome;   Anemia, Diamond-Blackfan;   Anemia, Aplastic
Intervention: Drug: Deferasirox
4 Recruiting Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
Conditions: Anemia, Aplastic;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Kostmann Syndrome
Intervention: Procedure: Allogeneic stem cell transplant
5 Recruiting A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Conditions: Aplastic Anemia;   Pure Red Cell Aplasia;   Diamond Blackfan Anemia
Interventions: Drug: Daclizumab;   Drug: Daclizumab (Zenapax)
6 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath® (Registered Trademark))
7 Completed Medical Treatment for Diamond Blackfan Anemia
Conditions: Fanconi's Anemia;   Hematologic Disease
Interventions: Drug: Antithymocyte globulin;   Drug: Cyclosporine
8 Recruiting Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed By Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia
Conditions: Fanconi Anemia;   Leukemia;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation
9 Completed Heart Disease in Sickle Cell Anemia
Conditions: Sickle Cell Anemia;   Pulmonary Hypertension
Intervention:
10 Active, not recruiting L-Glutamine Therapy for Sickle Cell Anemia
Conditions: Sickle Cell Anemia;   Thalassemia
Interventions: Drug: L-Glutamine;   Drug: Placebo
11 Completed Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Conditions: Cancer-Related Problem/Condition;   Congenital Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Fanconi Anemia;   Leukemia;   Severe Congenital Neutropenia
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy;   Procedure: umbilical cord blood transplantation
12 Active, not recruiting Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders;   Diamond-Blackfan Anemia;   Fanconi Anemia;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: melphalan;   Drug: methylprednisolone;   Drug: mycophenolate mofetil;   Procedure: radiation therapy;   Procedure: umbilical cord blood transplantation
13 Completed A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: ICA-17043
14 Active, not recruiting L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
Conditions: Sickle Cell Anemia;   Thalassemia
Intervention: Drug: L-glutamine
15 Recruiting Adherence to Hydroxyurea in Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Behavioral: Blood smear education;   Other: standard education
16 Recruiting Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
Condition: Fanconi Anemia
Intervention: Drug: Oxandrolone
17 Recruiting Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
Conditions: Sickle Cell Anemia;   Priapism;   Pulmonary Hypertension
Interventions: Drug: tadalafil;   Drug: placebo
18 Active, not recruiting Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
19 Completed Hydroxyurea in Young Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: hydroxyurea
20 Recruiting Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Hide Download Options
Download Content:




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services